S Farhan

Summary

Country: Austria

Publications

  1. doi request reprint Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
    Serdar Farhan
    Third Department of Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    Wien Med Wochenschr 160:30-8. 2010
  2. ncbi request reprint Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease
    S Farhan
    Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    Minerva Med 101:239-53. 2010
  3. doi request reprint Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus
    S Farhan
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Montleartstr 37, 1160, Vienna, Austria
    Herz 37:264-72. 2012
  4. ncbi request reprint Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort
    Tibor Szuk
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Am Heart J 153:289-95. 2007
  5. doi request reprint Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries
    Rayyan Hemetsberger
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Coron Artery Dis 19:635-43. 2008

Collaborators

Detail Information

Publications5

  1. doi request reprint Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
    Serdar Farhan
    Third Department of Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    Wien Med Wochenschr 160:30-8. 2010
    ..Enoxaparin and bivalirudin have been shown to be superior to UFH among patients with ST-elevation MI (STEMI) and non-ST elevation MI (NSTEMI) also in diabetic subgroup analyses...
  2. ncbi request reprint Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease
    S Farhan
    Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
    Minerva Med 101:239-53. 2010
    ..The role of several new antithrombins, i.e. direct factor Xa inhibitors or direct antithrombins in diabetic patients with stable or unstable CAD is still under investigation...
  3. doi request reprint Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus
    S Farhan
    3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Montleartstr 37, 1160, Vienna, Austria
    Herz 37:264-72. 2012
    ..This review article aims to shed light on and simplify antiplatelet and antithrombotic therapy in ACS patients with DM-2 in order to ease the clinician's decision-making...
  4. ncbi request reprint Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort
    Tibor Szuk
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Am Heart J 153:289-95. 2007
    ....
  5. doi request reprint Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries
    Rayyan Hemetsberger
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Coron Artery Dis 19:635-43. 2008
    ..We set out to compare the effectiveness of platelet aggregation therapy in association with the development of in-stent neointimal hyperplasia in porcine coronary arteries...